The effects of cyclodextrins on topical delivery of hydrocortisone: The aqueous diffusion layer

S.T.P. Pharma Sciences

Volumn 13, Issue 2, 2003, Pages 125-131

  Loftsson, T ^a   Sigfusson S D ^a   Sigurdsson, H H ^a   Masson M ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Aqueous diffusion layer; Cyclodextrin; Permeation; Topical drug delivery; Transdermal delivery

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CELLOPHANE; HYDROCORTISONE; POLYURETHAN; STEROID;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; FEMALE; FISH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; SKIN PERMEABILITY; STEADY STATE; STEROID THERAPY;

EID: 0037347663     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. McCARLEY K.D., BUNGE A.L. - Pharmacokinetic models of dermal absorption. - J. Pharm. Sci., 90, 1699-1719, 2001.
2. WALLACE S.M., BARNETT G. - Pharmacokinetic analysis of percutaneous absorption: evidence of parallel penetration pathways for methotrexate. - J. Pharmacokinet. Biopharm., 6, 315-325, 1978.
3. EDWARDS D.A., LANGER R. - A linear theory of transdermal transport phenomena. - J. Pharm. Sci., 83(9), 1315-1334, 1999.
4. HIGUCHI T. - Physical chemical analysis of percutaneous absorption process from creams and ointments. - J. Soc. Cosmetic Chemists, 11(2), 85-97, 1960.
5. HIGUCHI T. - Rate of release of medicaments from ointment bases containing drugs in suspension. - J. Pharm. Sci., 50, 874-875, 1961.
6. STEHLE R.G., HIGUCHI W.I. - In vitro model for transport of solutes in three-phase system. II. Experimental considerations. - J. Pharm. Sci., 61, 1931-1935, 1972.
7. FLYNN G.L., CARPENDER O.S., YALKOWSKY S.H. - Total mathematical resolution of diffusion layer control of barrier flux. - J. Pharm. Sci., 61, 312-314, 1972.
8. DÍES-SALES O., COPOVÍ A., CASABÓ V.G., HERRÁEZ M. - A modelistic approach showing the importance of the stagnant aqueous layers in in vitro diffusion studies, and in vitro-in vivo correlations. - Int. J. Pharm., 77, 1-11, 1991.
9. GERLÓCZY A., ANTAL S., SZEJTLI J. - Percutaneous absorption of heptakis-(2,6-di-O-14C-methyl)-β-cyclodextrin in rats. - In: Proceedings of the Fourth International Symposium on Cyclodextrins, O. Huber and J. Szejtli Eds., Kluwer Academic Publishers, Dordrecht, 1988, pp. 415-420.
10. MATSUDA H., ARIMA H. - Cyclodextrins in transdermal and rectal delivery. - Adv. Drug Deliv. Rev., 36, 81-99, 1999.
11. LOFTSSON T., MASSON M. - Cyclodextrins in topical drug formulations: theory and practice. - Int. J. Pharm., 225, 15-30, 2001.
12. UEKAMA K., HIRAYAMA F., IRIE T. - Cyclodextrin drug carrier systems. - Chem. Rev., 98, 2045-2076, 1998.
13. LOFTSSON T., SIGURDARDOTTIR A.M. - The effect of polyvinylpyrrolidone and hydroxypropyl methylcellulose on HPβCD complexation of hydrocortisone and its permeability through hairless mouse skin. - Eur. J. Pharm. Sci., 2, 297-301, 1994.
14. SIGURDARDOTTIR A.M., LOFTSSON T. - The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. - Int. J. Pharm., 126, 73-78, 1995.
15. CHO M.J., CHEN F.J., HUCZEK D.L. - Effects of inclusion complexation on the transepithelial transport of a lipophilic substance in vitro. - Pharm. Res., 12, 560-564, 1995.
16. KUBLIK H., BOCK T.K., SCHREIER H., MÜLLER B.W. - Nasal absorption of 17β-estradiol from different cyclodextrin inclusion formulations in sheep. - Eur. J. Pharm. Biopharm., 42, 320-324, 1996.
17. JARHO P., URTTI A., PATE D.W., SUHONEN P., JÄRVINEN T. - Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-β-cyclodextrin. - Int. J. Pharm., 137, 209-217, 1996.
18. CHANG S.L., BANGA A.K. - Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions. - J. Pharm. Pharmacol., 50, 635-640, 1998.
19. MASSON M., LOFTSSON T., MASSON G., STEFANSSON E. - Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. - J. Contr. Rel., 59, 107-118, 1999.
20. LOFTSSON T., JÄRVINEN T. - Cyclodextrins in ophthalmic drug delivery. - Adv. Drug Deliv. Rev., 36, 59-79, 1999.
21. ZUO Z., KWON G., STEVENSON B., DIAKUR J., WIEBE L.I. - Flutamide - hydroxypropyl-β-cyclodextrin complex: formulation, physical characterization, and absorption using the caco-2 in vitro model. - J. Pharm. Pharmaceut. Sci., 3, 220-227, 2000.
22. LOFTSSON T., STEFÁNSSON E. - Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. - Acta Ophthalmol. Scand., 80, 144-150, 2002.
23. ILLEL B., SCHAEFER H., WEPIERRE J., DOUCET O. - Follicles play an important role in percutaneous Absorption. - J. Pharm. Sci., 80(5), 424-427, 1991.
24. AGUILELLA V., BELAYA M., LEVADNY V. - Passive transport of small ions through human stratum comeum. - J. Control. Release, 44, 11-18, 1997.
25. MEIDAN M.V., DOCKER M., WALMSLEY A.D., IRWIN W.J. - Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption. - Pharm. Res., 15(1), 85-92, 1998.
26. LI S.K., SUH W., PARIKH H.H., GHANEM A.-H., MEHTA S.C., PECK K.D., HIGUCHI W.I. - Lag time data for characterizing the pore pathway of intact and chemically pretreated human epidermal membrane. - Int. J. Pharm., 170, 93-108, 1998.
27. SZNITOWSKA M., JANICKI S., WILLIAMS A.C. - Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. - J. Pharm. Sci., 87(9), 1109-1113, 1998.
28. AGARWAL R., KATARE O.P., VYAS S.P. - The pilosebaceous unit: a pivotal route for topical drug delivery. - Methods Find. Exp. Clin. Pharmacol., 22, 129-133, 2000.
29. PREISS A., MEHNERT W., FRÖMMING K.H. - In vitro hydrocortisone release from ointments in presence of cyclodextrins. - Pharmazie, 49, 902-906, 1994.
30. TWIST J.N., ZATZ J.L. - Influence of solvents on paraben permeation through idealized skin model membranes. - J. Soc. Cosmetic Chem., 37, 429-444, 1986.
31. LOFTSSON T., MÁSSON M., SIGURDSSON H.H. - Cyclodextrins and drug permeability through semi-permeable cellophane membranes. - Int. J. Pharm., 232, 35-43, 2002.
32. MÁSSON M., SIGFÚSSON S.D., LOFTSSON T. - Fish skin as a model membrane to study transmembrane drug delivery with cyclodextrins. - J. Incl. Phenom. Macroc. Chem., in press, 2003.
33. ARTURSSON P., UNGELL A.-L., LÖFROTH J.-E. - Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. - Pharm. Res., 10, 1123-1129, 1993.
34. HÄMÄLÄINEN K.M., KONTTURI K., AURIOLA S., MURTOMÄKI L., URTTI A. - Estimation of pore size and pore density of biomembranes from permeability measurements of polyethylene glycols using an effusion-like approach. - J. Control. Rel., 49, 97-104, 1997.
35. HÄMÄLÄINEN K.M., KANANEN K., AURIOLA S., KONTTURI K., URTTI A. - Characterization of paracellular and aqueous penetration routes in cornea conjunctiva, and sclera. - Invest. Ophthalmol. Vis. Sci., 38, 627-633, 1997.
36. HÄMÄLÄINENE K.M., RANTA V.-P., AURIOLA S., URTTI A. - Enzymatic and permeation barrier of [D-Ala2]-Metenkephalinamide in the anterior membranes of the albino rabbit eye. - Eur. J. Pharm. Sci., 9, 265-270, 2000.
37. KHANVILKAR K., DONOVAN M.D., FLANAGAN D.R. - Drug transfer through mucus. - Adv. Drug Deliv. Rev., 48, 173-193, 2001.
38. LOFTSSON T. - Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. - Pharmazie, 53, 733-740, 1998.